Skip to content
Biodatica
Start free

Investigator

Christopher Dockendorff

FUNCTION THERAPEUTICS, INC. · funded by NINDS, NIDDK

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$629k

Summed across those awards.

First award
May 15, 2024

Latest Sep 11, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    Parmodulins without Abuse Potential for the Treatment of Neuropathic Pain

    $500k

    Sep 11, 2025NINDSFUNCTION THERAPEUTICS, INC.NIH RePORTER · 11183315 (opens the source filing in a new tab)

  2. R43

    Small Molecule PAR1 Ligands for the Treatment of MASH

    $40k

    Aug 15, 2024NIDDKFUNCTION THERAPEUTICS, INC.NIH RePORTER · 11163456 (opens the source filing in a new tab)

  3. R43

    Inhibitors of Thromboinflammation for Acute Kidney Injury

    $89k

    May 15, 2024NIDDKFUNCTION THERAPEUTICS, INC.NIH RePORTER · 11087659 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources